Respiratory viruses are common in solid organ and hematopoietic stem cell transplant recipients and a recognized cause of significant morbidity and mortality. Epidemiology, risk factors, and attributable mortality in both populations are reviewed. In addition, virus-specific prevention and treatment options, including emerging investigational therapies, are discussed for respiratory syncytial virus, influenza, adenovirus, parainfluenza, and other respiratory viruses.
All Keywords
【저자키워드】 respiratory virus, solid organ transplant, Hematopoietic stem cell transplant,
【저자키워드】 respiratory virus, solid organ transplant, Hematopoietic stem cell transplant,